The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Open accessAbstract
bacteremia occurred after they had undergone FMT in two independent clinical trials; both cases were linked to the same stool donor by means of genomic sequencing. One of the patients died. Enhanced donor screening to limit the transmission of microorganisms that could lead to adverse infectious events and continued vigilance to define the benefits and risks of FMT across different patient populations are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMT may also carry the risk of unintended introduction of pathogens and antibiotic-resistant microbes into the recipients.749,750”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [749]
In the citing paper
“In 2019, it was reported that in two independent clinical trials, two patients developed bacteremia with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli after receiving FMT from the same donor, and one patient died [136].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · cites this paper as [136]
In the citing paper
“This issue has become extremely timely after the transmission of an extended-spectrum b -lactamase-producing Escherichia coli strain from a stool donor to two immunocompromised recipients who developed bacteremia, with a fatal outcome in one case. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Indeed, two cases of MDR bacteria transmission with life-threatening complications have been described in patients with cirrhosis and hematological malignancy after repeated FMT. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Although FMT is generally recognized as safe, with no or limited side effects,33 unexpected toxicity has been reported, e.g., extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bacteremia in two patients who received FMT.34”
From Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy149 · Cited by 1,163
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,118
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Self-citationSchürch, A. C., Arredondo-Alonso, S., Willems, R. J. L., & Goering, R. V. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.016 · Cited by 534
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 344
Research works printed but not linked: 1
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: CLSI supplement M100. 29th ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2019.
Cited by
Sorted by citations
Items 601–700 of 1,000
Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021
Zhang, T., Zhang, B., Tian, W., Wang, F., Zhang, J., Ma, X., Wei, Y., & Tang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.951004 · Cited by 13
Novel technologies to characterize and engineer the microbiome in inflammatory bowel disease
Boix-Amorós, A., Monaco, H., Sambataro, E., & Clemente, J. C. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2107866 · Cited by 13
Mapping the Landscape of Do-it-Yourself Medicine
Wexler, A. (2022) · Citizen Science Theory and Practice · doi:10.5334/cstp.553 · Cited by 14
Chopra, T. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2171986 · Cited by 13
Fecal microbiota transplantation holds the secret to youth
Meng, Y., Sun, J., & Zhang, G. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111823 · Cited by 14
Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors
Pei, B., Ma, X., Wu, N., Wang, C., & Yang, W. (2023) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2023.03.05 · Cited by 13
Clostridioides difficile Infection: Landscape and Microbiome Therapeutics.
Gawey, B. J., & Khanna, S. (2023) · PubMed Central · Cited by 13
Development of prime–boost-type next-generation mucosal vaccines
Fujimoto, K., & Uematsu, S. (2019) · International Immunology · doi:10.1093/intimm/dxz085 · Cited by 13
Zatorski, H., & Nakov, R. (2020) · Current Drug Targets · doi:10.2174/1389450121666200602125507 · Cited by 13
Recent advances in the treatment of Clostridioides difficile infection: the ever-changing guidelines
Khurana, S., Kahl, A., Yu, K., & Dupont, A. W. (2020) · Faculty Reviews · doi:10.12703/b/9-13 · Cited by 13
Kv, C. R. (2021) · Medicine in Microecology · doi:10.1016/j.medmic.2021.100033 · Cited by 13
Nicholson, M. R., Hourigan, S. K., Conrad, M. A., Goyal, A., Jensen, K., Kelsen, J. R., Kennedy, M., Weatherly, M., & Kahn, S. A. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001350 · Cited by 13
The Vaginal Virome in Women’s Health and Disease
Orton, K. L., & Monaco, C. L. (2025) · Microorganisms · doi:10.3390/microorganisms13020431 · Cited by 13
Dong, J., Xie, T., Shi, C., Feng, G., Zhang, H., Xu, Z., & Dong, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s543912 · Cited by 12
Gut microbiome, a novel precision medicine biomarker for hepatocellular carcinoma
Chen, P., Devkota, S., Shiao, S. L., Hendifar, A. E., & Yang, J. D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1568962 · Cited by 12
Host–gut microbiota interactions in health and disease: mechanisms and intervention strategies
Han, Y., Wang, Z., Xie, J., Yang, G., Su, M., Wang, S., Yang, M., Yu, H., Li, M., Wang, L., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1785607 · Cited by 13
Role of bacteria and microbial metabolites in immune modulation during early life
Oldereid, T. S., Jiang, X., Nordhus, K. S., Ponzetta, A., Bjørnholt, J. V., Björkström, N. K., Melum, E., & Rasmussen, H. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13336 · Cited by 12
Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure
Saeidinejad, M., Shabrawi, A. E., Sriphoosanaphan, S., Andreola, F., Mehta, G., Agarwal, B., & Jalan, R. (2023) · Seminars in Liver Disease · doi:10.1055/s-0043-1776773 · Cited by 12
Xiao, Y., Duan, J., Tan, C., Zou, J., Chen, S., Liu, T., Zhang, L. N., Chen, X., Xu, Y., Li, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76261-9 · Cited by 12
Ueckermann, V., Hoosien, E., de Villiers, N., & Geldenhuys, J. (2020) · Case Reports in Infectious Diseases · doi:10.1155/2020/8462659 · Cited by 12
Modulating the gut–liver axis and the pivotal role of the faecal microbiome in cirrhosis
Woodhouse, C., Singanayagam, A., & Patel, V. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0676 · Cited by 12
Intestinal microbiota: The hidden gems in the gut?
Piewngam, P., Mets, F. D., & Otto, M. J. (2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-020720-0897 · Cited by 14
Kaźmierczak-Siedlecka, K., Skonieczna‐Żydecka, K., Biliński, J., Roviello, G., Iannone, L. F., Atzeni, A., Sobocki, B. K., & Połom, K. (2021) · Cancers · doi:10.3390/cancers13184665 · Cited by 12
Lee, P., Chang, T.-E., Wang, Y., Lee, K., Lin, Y.-T., Chiou, J.-J., Huang, C.-W., Yang, U., Li, F.-Y., Huang, H., et al. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.11.001 · Cited by 12
Piazzesi, A., & Putignani, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.958346 · Cited by 12
Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection
Bloom, P. P., & Young, V. B. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2154600 · Cited by 12
Self-citationLeveraging the microbiome in the treatment of sepsis: potential pitfalls and new perspectives
Biemond, J. J., McDonald, B., & Haak, B. W. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001019 · Cited by 12
Gray, A., & DeFilipp, Z. M. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.05.007 · Cited by 12
Self-citationFecal Microbiota Transplant in Pediatric Solid Organ Transplant Recipients
Rodig, N., Weatherly, M., Kaplan, A. L., Ballal, S. A., Elisofon, S. A., Daly, K. P., & Kahn, S. A. (2023) · Transplantation · doi:10.1097/tp.0000000000004656 · Cited by 12
From support to therapy: rethinking the role of nutrition in acute graft-versus-host disease
Limpert, R., Pan, P., Wang, L., & Chen, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192084 · Cited by 12
Drug and gut microbe relationships: Moving beyond antibiotics
Kumbhare, S. V., Pedroso, I., Ugalde, J. A., Márquez‐Miranda, V., Sinha, R., & Almonacid, D. E. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103797 · Cited by 12
Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?
Sharma, S., Sharma, H., & Gogoi, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1277677 · Cited by 13
Protecting Intestinal Microenvironment Alleviates Acute Graft-Versus-Host Disease
Zhou, Z., Shang, T., Li, X., Zhu, H., Qi, Y., Zhao, X., Chen, X., Shi, Z., Pan, G., Wang, Y., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.608279 · Cited by 12
Bacteria and Sepsis: Microbiome to the Rescue?
Kang, H., & Thomas, R. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163578 · Cited by 12
Yang, B. K., Tian, H., Ye, C., Lin, Z., Zhao, D., Ma, C., Zhao, J., Wu, S., Jiang, R., Li, N., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.746990 · Cited by 12
Kelly, C. R., Laine, L., & Wu, G. D. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.039 · Cited by 12
Zhang, X., Huang, K., Wu, Z., Ding, R., Han, J., Zhang, Y., Lu, Y., Lu, Y., & Si, Y. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108971 · Cited by 12
Intestinal microecology-based treatment for inflammatory bowel disease: Progress and prospects
Yan, X.-X., & Dong, W. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i1.47 · Cited by 11
Harrison, M. A., Farthing, R. J., Allen, N., Ahern, L. M., Birchall, K., Bond, M., Kaur, H., Wren, B. W., Bergeron, J. R. C., & Dawson, L. F. (2023) · Scientific Reports · doi:10.1038/s41598-023-32656-8 · Cited by 11
The Current and Future State of Microbiome Therapeutics in Liver Disease
Bloom, P. P., & Bajaj, J. S. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002581 · Cited by 11
Self-citationEffect of GVHD on the gut and intestinal microflora
Ji, H., Feng, S., Liu, Y., Cao, Y., Lou, H., & Li, Z. (2024) · Transplant Immunology · doi:10.1016/j.trim.2023.101977 · Cited by 11
Therapeutic manipulation of the microbiome in liver disease
Parthasarathy, G., Malhi, H., & Bajaj, J. S. (2024) · Hepatology · doi:10.1097/hep.0000000000000987 · Cited by 12
Alcohol-associated liver disease: Emerging therapeutic strategies
Mullish, B. H., & Thursz, M. R. (2024) · Hepatology · doi:10.1097/hep.0000000000000986 · Cited by 11
Yin, Q., Ni, J., & Ying, J. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1263 · Cited by 12
The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies
Yaghmaei, H., Bahanesteh, A., Soltanipur, M., Takaloo, S., Rezaei, M., & Siadat, S. D. (2024) · International Journal of Hepatology · doi:10.1155/2024/4183880 · Cited by 11
Precision microbial regulation: Strategies for modulating GIT microbiota for host health
Pei, Z., Li, Q., Zhang, Y., Guo, C., Abdelsattar, M. M., & Bi, Y. (2025) · iMetaOmics. · doi:10.1002/imo2.54 · Cited by 12
Singh, C., Singh, A., Singh, D., & Upadhyay, R. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100121 · Cited by 11
Alonso, C. D., Tillotson, G., Bidell, M. R., Guthmueller, B., Hoeyer, F., Fischer, M., & Dubberke, E. R. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf117 · Cited by 11
Jha, M., Waheed, A., Hooti, J. A., Nair, S., Najam, A., Mal, M. M., Tummala, N., Shariq, A. S., Hurairah, A., & Daniel, M. G. (2025) · Health Science Reports · doi:10.1002/hsr2.71157 · Cited by 11
Cabral, V., Oliveira, R. A., Correia, M. B., Pedro, M. F., Garcia‐Garcerà, M., Úbeda, C., & Xavier, K. B. (2025) · Nature Communications · doi:10.1038/s41467-025-67015-w · Cited by 11
Prophage in Phage Manufacturing: Is the Risk Overrated Compared to Other Therapies or Food?
Gabard, J. (2020) · Antibiotics · doi:10.3390/antibiotics9080435 · Cited by 11
Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis
Lemos, M. P. C., Zucoloto, T. G., Oliveira, M. C., & de Oliveira, G. L. V. (2021) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001748 · Cited by 11
Lipids from gut microbiota: pursuing a personalized treatment
Carneiro, P. V., Montenegro, N. D. A., Lana, A. J., Amato, A. A., & Santos, G. M. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.06.001 · Cited by 12
Tucker, E. C., Haylock‐Jacobs, S., Rapaic, M., Dann, L. M., Bryant, R. V., & Costello, S. P. (2023) · JGH Open · doi:10.1002/jgh3.12874 · Cited by 11
Faecal microbiota transplantation: indications, evidence and safety
Soo, W. T., Bryant, R. V., & Costello, S. P. (2020) · Australian Prescriber · doi:10.18773/austprescr.2020.014 · Cited by 12
A contemporary review of Clostridioides difficile infections in patients with haematologic diseases
Dutta, D., Jafri, F. M., STUHR, D., Knoll, B. M., & Lim, S. H. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13173 · Cited by 13
Hoffmann‐Vold, A., Fretheim, H., Sarna, V. K., Barua, I., Carstens, M. N., Distler, O., Khanna, D., Volkmann, E. R., Midtvedt, Ø., Didriksen, H., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048541 · Cited by 11
Plant-Derived Xanthones against Clostridial Enteric Infections
Liu, Y., Zhu, J., Qu, S., Shen, J., & Zhu, K. (2023) · Antibiotics · doi:10.3390/antibiotics12020232 · Cited by 10
Guo, J., Zhou, B., Niu, Y., Liu, L., & Yang, L. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01279-1 · Cited by 10
Lauko, S., Gancarčíková, S., Hrčková, G., Hajdučková, V., Andrejčáková, Z., Fecskeová, L. K., Bertková, I., Hijová, E., Kamlárová, A., Janíčko, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines12010043 · Cited by 10
Acharya, S., & Thirunavukkarasu, C. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2902067 · Cited by 10
Zhang, X., Wan, L., Zheng, Y., & Ai, Y. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl27747 · Cited by 10
Odenwald, M. A., Ramaswamy, R., Lin, H., Lehmann, C. J., Moran, A., Mullowney, M. W., Sidebottom, A. M., Hernández, A. B., McMillin, M., Rose, A. R., et al. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100695 · Cited by 10
Gut dysbiosis and its treatment in patients with critical illness
Shimizu, K., Ogura, H., & Oda, J. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70068 · Cited by 11
Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease
Ma, L., Zhang, M., Xu, Y., Hao, Y.-X., Niu, X.-X., Li, Y., & Xing, H. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i28.105089 · Cited by 13
Koelsch, N. J., & Manjili, M. H. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03133-y · Cited by 10
Urbonas, T., Ianiro, G., Gedgaudas, R., Šabanas, P., Urba, M., Kiudelis, V., Kiudelis, G., Petkevičius, V., Vitkauskienė, A., Cammarota, G., et al. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3800 · Cited by 10
Global trends in gut microbiota and clostridioides difficile infection research: A visualized study
Li, Z., Ke, H., Lin, Q., Shen, Z., & Chen, Y. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.06.011 · Cited by 10
Self-citationRamos, R. J., Zhu, C., Joseph, D. F., Thaker, S., LaComb, J. F., Markarian, K., Lee, H., Petrov, J. C., Monzur, F., Buscaglia, J. M., et al. (2022) · Medical Research Archives · doi:10.18103/mra.v10i10.3318 · Cited by 10
Jugan, M. C., KuKanich, K. S., & Freilich, L. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1050538 · Cited by 10
Design of 8-mer peptides that block Clostridioides difficile toxin A in intestinal cells
Sarma, S., Catella, C. M., Pedro, E. T. S., Xiao, X., Durmusoglu, D., Menegatti, S., Crook, N., Magness, S. T., & Hall, C. K. (2023) · Communications Biology · doi:10.1038/s42003-023-05242-x · Cited by 10
Tyus, D., Leslie, J. L., Naz, F., Uddin, M. J., Thompson, B. A., & Petri, W. A. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101771 · Cited by 10
Chiu, C., Tsai, M., Cheng, H., Le, P., Kuo, C., & Chiu, C. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.07.028 · Cited by 10
Sustainable Microbiome: a symphony orchestrated by synthetic phages
Mirzaei, M. K., & Deng, L. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13697 · Cited by 10
Xie, Y., Estrada, A. C., Nelson, B., Feng, H., Pothoulakis, C., Chesnel, L., & Koon, H. W. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1072534 · Cited by 10
LASTOURS, V. D., Poirel, L., Huttner, B. D., Harbarth, S., Denamur, É., & Nordmann, P. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.01.003 · Cited by 10
Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime?
Cheng, Y., & Fischer, M. (2020) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.08.006 · Cited by 10
Designing bugs as drugs: exploiting the gut microbiome
Lamousé-Smith, E. S. N., Kelly, D., & de Cremoux, I. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00381.2019 · Cited by 11
The potential of fecal microbiota transplantation in systemic sclerosis
Hoffmann‐Vold, A., Fretheim, H., Didriksen, H., & Molberg, Ø. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1707665 · Cited by 10
Weber, D., Meedt, E., Poeck, H., Orberg, E. T., Hiergeist, A., Gessner, A., & Holler, E. (2024) · Visceral Medicine · doi:10.1159/000538303 · Cited by 11
Research advances on short-chain fatty acids in gastrointestinal acute graft- versus -host disease
Song, X., Lao, J., Wang, L., & Liu, S. (2024) · Therapeutic Advances in Hematology · doi:10.1177/20406207241237602 · Cited by 9
The Role of Gut Microbiota in Male Erectile Dysfunction of Rats
Xu, Z., Wang, S., Liu, C.-X., Kang, J., Pan, Y., Zhang, Z., Zhou, H., Xu, M., Li, X., Wang, H. Y., et al. (2024) · The World Journal of Men s Health · doi:10.5534/wjmh.230337 · Cited by 9
Gut-Heart Axis: Microbiome Involvement in Restrictive Cardiomyopathies
Alvarado, S. J., López-Tenorio, I. I., Santos, J. B.-D. L., Bello-Vega, D. C., Roldán, F., Amedei, A., Berrios-Bárcenas, E. A., & Aguirre‐García, M. M. (2025) · Biomedicines · doi:10.3390/biomedicines13010144 · Cited by 9
Pakuwal, E., Tan, J. L., Woodman, R. J., Page, A. J., Stringer, A. M., & Chinnaratha, M. A. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003003 · Cited by 9
Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice
Millard, S., Vendrov, K. C., Young, V. B., & Seekatz, A. M. (2025) · mBio · doi:10.1128/mbio.01108-25 · Cited by 10
Zhao, X., Cai, Y., Hou, Y., Wu, Y., Wei, T., Li, L., Duan, Z., Lu, X., Meng, J., Zhou, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202505204 · Cited by 9
Elendu, C., Omeludike, E., Aregbesola, E. T., Mordi, P., Blewusi, G. S., Ogidan, A. O., Okeke, N. S., Obidigbo, B. T., Asini, A. O., Ubi, E. S., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003649 · Cited by 9
Sala, L. L., Carlini, V., Macas-Granizo, M. B., Trabucchi, E., Pontiroli, A. E., Berra, C., Naselli, A., D’Anzeo, M., Porta, A., Martín-Delgado, J., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.021 · Cited by 9
Gut microbiota in cancer cachexia: a new frontier for research and therapy
Ardis, C. K., Bui, T. P. N., & Nieuwdorp, M. (2025) · Genes & Nutrition · doi:10.1186/s12263-025-00791-8 · Cited by 9
Diet, the Gut Microbiome, and Estrogen Physiology: A Review in Menopausal Health and Interventions
Lim, M. J. S., Parlindungan, E., See, E., Gan, C. H., Yap, R., & Yong, G. J. M. (2026) · Nutrients · doi:10.3390/nu18071052 · Cited by 9
Nanjing Consensus II on Washed Microbiota Transplantation: Statements From the CHINAGUT Conference
Zhang, F., Wong, H. S., Lu, G., Pi, Z., Zhang, T., Yu, H. H., Bu, N., Chen, X., Cui, B., Dafa, D., et al. (2026) · Microbiota Medicine Research · doi:10.1002/mmr3.70006 · Cited by 9
Systems approaches for the clinical diagnosis of Clostridioides difficile infection
Wu, Q., & Savidge, T. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.006 · Cited by 9
Vaccine therapy for dysbiosis-related diseases
Fujimoto, K., & Uematsu, S. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i21.2758 · Cited by 9
Islam, M. I., Seo, H., Asma, R., Kim, S. K., Lee, S., Siddiquee, M., & Song, H. (2021) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2107.07057 · Cited by 9
Chen, C., Chen, L., Sun, D., Li, C., Xi, S., Ding, S., Luo, R., Geng, Y., & Bai, Y. (2022) · Gut Pathogens · doi:10.1186/s13099-022-00491-3 · Cited by 9
Aktories, K. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02300-9 · Cited by 9
Gweon, T., Lee, Y. J., Yim, S. K., Kim, S. Y., Choi, C. H., & Cho, Y. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.206 · Cited by 9
Minimizing the Risks of Simethicone in Endoscope Reprocessing
Speer, T., Vickery, K., Alfa, M. J., & Sáenz, R. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001807 · Cited by 9
Dietary fungi in cancer immunotherapy: From the perspective of gut microbiota
Wei, Y., Song, D., Wang, R., Li, T., Wang, H., & Li, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1038710 · Cited by 9
Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors
Ma, J., Wei, Q., Cheng, X. M., Zhang, J., Zhang, Z., & Su, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1170591 · Cited by 9
Metadata
- Authors
- DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L.
- Affiliations
- Harvard University (US)
- From the Blood and Marrow Transplant Program (Z.D., Y.-B.C.), the Liver Center, Division of Gastroenterology (P.P.B., R.T.C.), and the Division of Infectious Diseases (M.T.S., M.K.M., S.T., E.L.H.), Massachusetts General Hospital, Harvard Medical School (Z.D., P.P.B., M.T.S., M.K.M., S.T., R.T.C., Y.-B.C., E.L.H.), and Day Zero Diagnostics (M.R.A.S., M.H.H.) — all in Boston.
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-11-21
- Volume
- 381
- Issue
- 21
- Pages
- 2043-2050
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2982566732
- Cited by
- 1,281
- References
- 26
- Citations by year
- 2026: 202 · 2025: 160 · 2024: 158 · 2023: 175 · 2022: 169 · 2021: 184 · 2020: 222 · 2019: 10
- FWCI
- 112.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- drug-resistant Escherichia coli, bacteremia, fecal microbiota transplantation, donor screening, genome sequencing
- MeSH terms
- Fecal Microbiota Transplantation, Aged, beta-Lactamases, Escherichia coli, Feces, Hepatic Encephalopathy, Humans, Male, Myelodysplastic Syndromes, Bacteremia, Fatal Outcome, Drug Resistance, Bacterial, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
